| 000 | 01465 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513170948.0 | ||
| 264 | 0 | _c19990415 | |
| 008 | 199904s 0 0 eng d | ||
| 022 | _a0041-1345 | ||
| 024 | 7 |
_a10.1016/s0041-1345(98)01646-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFirst, M R | |
| 245 | 0 | 0 |
_aNine-month follow-up of SangCya (Sang-35) in kidney transplant patients after conversion from Sandimmune. _h[electronic resource] |
| 260 |
_bTransplantation proceedings _c |
||
| 300 |
_a324-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 |
_aCyclosporine _xadministration & dosage |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aKidney Transplantation _ximmunology |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aWeiskittel, P | |
| 700 | 1 | _aBurton, M L | |
| 700 | 1 | _aShah, M B | |
| 700 | 1 | _aDreyer, D | |
| 700 | 1 | _aFleck, P | |
| 700 | 1 | _aBey, C | |
| 700 | 1 | _aPeddi, V R | |
| 700 | 1 | _aCanafax, D M | |
| 700 | 1 | _aSchroeder, T J | |
| 773 | 0 |
_tTransplantation proceedings _gvol. 31 _gno. 1-2 _gp. 324-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0041-1345(98)01646-7 _zAvailable from publisher's website |
| 999 |
_c10042909 _d10042909 |
||